Principal Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,988
Closed -$51K 2313
2019
Q1
$51K Buy
10,988
+335
+3% +$1.59K ﹤0.01% 2182
2018
Q4
$37K Sell
10,653
-480
-4% -$3.34K ﹤0.01% 2215
2018
Q3
$112K Buy
11,133
+366
+3% +$2.92K ﹤0.01% 2227
2018
Q2
$78K Sell
10,767
-2,298
-18% -$16K ﹤0.01% 2233
2018
Q1
$79K Buy
13,065
+1,179
+10% +$9.73K ﹤0.01% 2165
2017
Q4
$114K Buy
+11,886
New +$77.8K ﹤0.01% 2178

Other funds holding INSY

Principal Financial Group's INSY Position: Q2 2019 in Review

Principal Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 10,988 shares — an estimated $51K sold.

Principal Financial Group first reported a position in INSY in Q4 2017 and held it in 6 quarters. The position peaked at $114K in Q4 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Principal Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Principal Financial Group sold 10,988 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $51K.
  • Principal Financial Group first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
  • Principal Financial Group's Insys Therapeutics, Inc. position peaked at $114K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Principal Financial Group's 13F filing for Q2 2019, filed 12 Aug 2019.